GPR110 overexpression increases tumorigenic potential of HER2+breast cancer cells

被引：1
|
作者：
Trivedi, M. V.
Bhat, R.
Yadav, V.
Yadav, P.
Ai-Rawi, A.
Christiny, P.
Nanda, S.
Giuliano, M.
Creighton, C.
Osborne, C. K.
Narkar, V. A.
Schiff, R.
机构：
[1] Univ Houston, Coll Pharm, Houston, TX 77030 USA
[2] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Dan L Duncan Canc Ctr, Houston, TX 77030 USA
[3] Baylor Coll Med, Houston, TX 77030 USA
[4] Univ Texas Houston, Inst Mol Med, Ctr Metab & Degenerat Dis, Houston, TX USA
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P6-04-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-04-05
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Treatment of ER+/HER2+breast cancer
    Johnston, Stephen
    CANCER RESEARCH, 2023, 83 (05)
  • [22] Effect of FAK Activation HER2+Breast Cancer
    Quintana, Victoria Gabriela
    Byrd, Sherell
    FASEB JOURNAL, 2019, 33
  • [23] Intrinsic molecular subtypes of HER2+breast cancer
    Prat, Aleix
    Pascual, Tomas
    Adamo, Barbara
    ONCOTARGET, 2017, 8 (43) : 73362 - 73363
  • [24] Recent insights into the biology of HER2+breast cancer
    Prat, A.
    CANCER RESEARCH, 2017, 77
  • [25] The role of SHP2 in HER2+breast cancer
    Wang, Xiaonan
    CANCER RESEARCH, 2012, 72
  • [26] GPR110 promotes progression and metastasis of triple-negative breast cancer (vol 8, 271, 2022)
    Nam, Hye-Jung
    Kim, Yeon-Ju
    Kang, Jae-Hyeok
    Lee, Su-Jae
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [27] Visualizing trastuzumab-deruxtecan action in HER2+breast cancer cells at nanoscale
    Cortese, K.
    Garrone, O.
    Gagliani, M. C.
    Bellese, G.
    Arnaldi, P.
    Abbona, A.
    Paccagnella, M.
    Ruatta, F.
    Merlano, M. C.
    Castagnola, P.
    ANNALS OF ONCOLOGY, 2023, 34 : S197 - S197
  • [28] Identification of potential target genes of cardiac glycosides from Vernonia amygdalina Delile in HER2+breast cancer cells
    Hermawan, Adam
    Satria, Denny
    Hasibuan, Poppy Anjelisa Zaitun
    Huda, Fathul
    Tafrihan, Ahmad Syauqy
    Fatimah, Nurul
    Putri, Dyaningtyas Dewi Pamungkas
    SOUTH AFRICAN JOURNAL OF BOTANY, 2024, 164 : 401 - 418
  • [29] Involvement of microRNA-146a in trastuzumab resistance of HER2+breast cancer cells
    Cabello, P.
    Fores, J.
    Tormo, E.
    Pineda, B.
    Adam, A.
    Garrido, I.
    Pattanayak, B.
    Lluch, A.
    Eroles, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [30] Autophagy, cancer stem cells, and trastuzumab resistance in three dimensional cultures of HER2+breast cancer cells
    Rodriguez, Cristina E.
    Reidel, Sara
    Adela Jasnis, Maria
    Bal de Kier Joffe, Elisa
    Fiszman, Gabriel L.
    CANCER RESEARCH, 2015, 75
12345